Personal information

Websites & social links

https://www.linkedin.com/in/ivan-sloma-2149799/

Countries

France

Activities

Collapse all

Employment (4)

Paris-Est Creteil Université - Faculty of Medicine, AP-HP: CRETEIL, FR

2023-09-01 to present | Professor PU-PH (Hematology)
Employment
Source: Self-asserted source
Ivan Sloma

Université Paris Est Créteil - Faculté de Médecine AP-HP: Créteil, FR

2018-09-01 to present | Associate professor (MCU-PH) (INSERM U955 Team 9 & Hematology and Immunology Department)
Employment
Source: Self-asserted source
Ivan Sloma

Université Paris-Sud Faculté de Médecine - AP-HP: Le Kremlin-Bicetre, Île-de-France, FR

2013-09-01 to 2018-08-30 | Associate professor (INSERM U955 & Hematology Department)
Employment
Source: Self-asserted source
Ivan Sloma

Université Paris-Sud Faculté de Médecine AP-HP: Le Kremlin-Bicetre, Île-de-France, FR

2010-09-01 to 2013-08-30 | Assistant professor (INSERM U955 & Hematology Department)
Employment
Source: Self-asserted source
Ivan Sloma

Education and qualifications (5)

BC Cancer Agency: Vancouver, BC, CA

2008-02-25 to 2010-09-30 | Post-Doc fellowship (Terry Fox Laboratory - Pr Connie Eaves)
Education
Source: Self-asserted source
Ivan Sloma

Université Paris Descartes: Paris, Île-de-France, FR

2003 to 2007 | PhD (INSERM U662)
Education
Source: Self-asserted source
Ivan Sloma

Université Paris Descartes: Paris, Île-de-France, FR

2000-11-01 to 2005-10-31 | Laboratory Medicine Residency (Assistance Publique - Hôpitaux de Paris)
Education
Source: Self-asserted source
Ivan Sloma

Université Paris Descartes: Paris, Île-de-France, FR

1995 to 2005 | PharmD
Education
Source: Self-asserted source
Ivan Sloma

Université Paris Descartes: Paris, Île-de-France, FR

2002-09 to 2003-06 | Master 2 - Immunology (INSERM U662)
Education
Source: Self-asserted source
Ivan Sloma

Works (34)

Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia

Leukemia & Lymphoma
2024-10-14 | Journal article
DOI: 10.1080/10428194.2024.2378816
Contributors: Violaine Tran Quang; Orianne Wagner-Ballon; Ivan Sloma
Source: check_circle
Crossref

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia

Leukemia Research Reports
2023 | Journal article
DOI: 10.1016/j.lrr.2023.100366
Part of ISSN: 2213-0489
Contributors: Félicité de Charry; Johanna Konopacki; Sarah Bugier; Vincent Foissaud; Ivan Sloma; Jean-Valère Malfuson; Pierre Arnautou
Source: Self-asserted source
Ivan Sloma

ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case‐story with two successive HLA‐matched sibling donors

American Journal of Hematology
2023-04 | Journal article
DOI: 10.1002/ajh.26808
Contributors: Rabah Redjoul; Florence Beckerich; Gonzalo de Luna; Mathieu Leclerc; Nicolas Hebert; Ivan Sloma; Dehbia Menouche; Pablo Bartolucci; Sébastien Maury
Source: check_circle
Crossref

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia

Haematologica
2023-04-27 | Journal article
DOI: 10.3324/haematol.2022.282528
Part of ISSN: 1592-8721
Part of ISSN: 0390-6078
Contributors: Violaine Tran Quang; Benjamin Podvin; Christophe Desterke; Sihem Tarfi; Quentin Barathon; Bouchra Badaoui; Nicolas Freynet; Vincent Parinet; Mathieu Leclerc; Sébastien Maury et al.
Source: Self-asserted source
Ivan Sloma

Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients

American journal of hematology
2022 | Journal article
DOI: 10.1002/ajh.26593
Part of ISSN: 0361-8609
Source: Self-asserted source
Ivan Sloma

High prevalence of unusual KRAS, NRAS and BRAF mutations in POLE hypermutated colorectal cancers

Molecular oncology
2022 | Journal article
DOI: 10.1002/1878-0261.13257
Part of ISSN: 1574-7891
Source: Self-asserted source
Ivan Sloma

Leukaemic evolution of rare donor CSF3R germline mutation after umbilical cord blood transplant

British journal of haematology
2022 | Journal article
DOI: 10.1111/bjh.18078
Part of ISSN: 0007-1048
Source: Self-asserted source
Ivan Sloma

Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection.

Molecular oncology
2022-10-17 | Journal article | Author
DOI: 10.1002/1878-0261.13311
PMID: 36062346
PMC: PMC9718115
Contributors: Loëtitia Favre; Sako N; Tarfi S; Quang VT; Joy C; Dupuy A; Guillerm E; Gaulard P; Wagner-Ballon O; Anaïs Pujals et al.
Source: Self-asserted source
Ivan Sloma

Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression.

Haematologica
2021-03-01 | Journal article
DOI: 10.3324/haematol.2020.249243
PMID: 32499242
PMC: PMC7927998
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Blood advances
2021-03-01 | Journal article
DOI: 10.1182/bloodadvances.2020003444
PMID: 33666653
PMC: PMC7948260
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.

Leukemia
2020-07-20 | Journal article
DOI: 10.1038/s41375-020-0955-1
PMID: 32684630
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state.

Haematologica
2019-08-14 | Journal article
DOI: 10.3324/haematol.2019.219782
PMID: 31413091
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

PloS one
2018 | Journal article
DOI: 10.1371/journal.pone.0200923
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia

Leukemia & lymphoma
2017 | Journal article
DOI: 10.1080/10428194.2016.1201575
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia

Experimental hematology
2017 | Journal article
DOI: 10.1016/j.exphem.2017.05.007
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.9182
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

A Bio-Integrative Approach Identifies an Inflammatory Signature in Chronic Myeloid Leukemia (CML) Stem Cells That Is Highly Perturbed in CML Blast Crisis and Involves REL transcription Factor

Blood
2015 | Conference paper
Source: Self-asserted source
Ivan Sloma

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

Blood
2015 | Journal article
DOI: 10.1182/blood-2014-06-581173
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Success of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera

Leuk Lymphoma
2015 | Journal article
DOI: 10.3109/10428194.2015.1009057
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 3)‎

Haemophagocytic histiocyte in a peripheral blood film

Br J Haematol
2014 | Journal article
DOI: 10.1111/bjh.12697
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 3)‎

A Novel TWIST2-ID2 Axis That Modulates The Growth and Imatinib Sensitivity Of CML CD34+ Cells

Blood
2013 | Conference paper
Source: Self-asserted source
Ivan Sloma

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Blood
2013 | Conference paper
Source: Self-asserted source
Ivan Sloma

Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene

Leukemia
2013 | Journal article
DOI: 10.1038/leu.2012.196
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia

Experimental hematology
2013 | Journal article
DOI: 10.1016/j.exphem.2013.07.001
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex

J Natl Cancer Inst
2013 | Journal article
DOI: 10.1093/jnci/djt006
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 3)‎

Whole Genome Sequencing Of Chronic Myeloid Leukemia (CML)-Derived Induced Pluripotent Stem Cells (iPSC) Reveals Faithful Genocopying Of Highly Mutated Primary Leukemic Cells

Blood
2013 | Conference paper
Source: Self-asserted source
Ivan Sloma

Insights into the stem cells of chronic myeloid leukemia.

Leukemia
2010 | Journal article
DOI: leu2010159 [pii] 10.1038/leu.2010.159
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security

Journal of leukocyte biology
2009 | Journal article
DOI: 10.1189/jlb.0308206
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

TEL me all

Cell stem cell
2009 | Journal article
DOI: 10.1016/j.stem.2009.06.011
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts

Journal of immunology (Baltimore, Md. : 1950)
2008 | Journal article
DOI: 10.4049/jimmunol.180.2.980
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia

Human immunology
2007 | Journal article
DOI: 10.1016/j.humimm.2007.08.260
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Tuberculosis in adult patients with sickle cell disease

The Journal of infection
2007 | Journal article
DOI: 10.1016/j.jinf.2007.07.001
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism

Human immunology
2005 | Journal article
DOI: 10.1016/j.humimm.2005.09.004
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎

Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease

Human immunology
2004 | Journal article
DOI: 10.1016/j.humimm.2004.09.009
Source: Self-asserted source
Ivan Sloma
grade
Preferred source (of 2)‎
How many people are using ORCID?